Watch Your Mate's Back: helping young Australians recognise melanoma
30 November 2015
‘Watch Your Mate’s Back’, in partnership with Surf Life Saving Australia, focuses on three simple steps: prevent, detect and act.
MIA’s Executive Director, Professor John Thompson said: “Checking your own skin is one of the most effective ways of detecting melanoma. We all need to watch for skin lesions that change in size, shape or colour, develop an irregular border, become itchy or repeatedly bleed.
“Of course there are hard-to-see places on our own bodies. One quarter of melanomas are detected by someone other than the person with the melanoma. That’s what makes ‘Watch Your Mate’s Back’ an important summer awareness campaign.”
Professor Thompson added: “Australia has the highest incidence of melanoma in the world. Up to 90% of melanomas are triggered by UV radiation from the sun. To reduce the risk we need to adopt sun-safe practices such as wearing sun protective clothing and a hat, seeking shade when possible and applying sunscreen.”
Sky News presenter Jacinta Tynan hosted the campaign launch and celebrity personal trainer Shannan Ponton spoke about his own melanoma diagnosis. NSW Surf Lifesaver of the Year Rosie Taliano and former Ironman Champion Guy Leech were also on hand to help spread awareness about melanoma, the most serious form of skin cancer.
Visit the Watch Your Mate’s Back website to learn more and to download resources.
Join us at the 2nd Melanoma Patients Australia webinar 'Psychological Health & Wellbeing'.
You're invited to be a C2S charity superstar, and together we can run over melanoma!
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.